The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond
Journal of Advanced Research · 2025
DOI: 10.1016/j.jare.2024.01.034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Advanced Research, 2025. Verfasst von Hong Hui Jing und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM), Pulau Pinang 11800, Malaysia. Hauptthemen laut MEDLINE: Carbon, Nanomedicine, Neoplasms, Quantum Dots. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universiti Sains Malaysia, Deanship of Scientific Research, King Khalid University, Georgia Research Alliance.
Abstract (Originalsprache)
BACKGROUND: The emergence of carbon dots (CDs) as anticancer agents had sparked a transformation in cancer research and treatment strategies. These fluorescent CDs, initially introduced in the early 2000 s, possess exceptional biocompatibility, tunable fluorescence, and surface modification capabilities, positioning them as promising tools in biomedical applications. AIM OF REVIEW: The review encapsulates the transformative trajectory of green CDs as future anticancer nanomedicine, poised to redefine the strategies employed in the ongoing fight against cancer. KEY SCIENTIFIC CONCEPTS OF REVIEW: The versatility of CDs was rooted in their various synthesis approaches and sustainable strategies, enabling their adaptability for diverse therapeutic uses. In vitro studies had showcased CDs' selective cytotoxicity against cancer cells while sparing healthy counterparts, forming the basis for targeted therapeutic potential. This selectivity had been attributed to the reactive oxygen species (ROS) generation, which opened avenues for targeted interventions. The role of CDs in combination therapies, synergizing with chemotherapy, radiotherapy, and targeted approaches was then investigated to heighten their anticancer efficacy. Notably, in vivo studies highlight CDs' remarkable biocompatibility and minimal side effects, endorsing their translational promise. Integration with conventional cancer treatments such as chemotherapy, radiotherapy, and immunotherapy amplified the versatility and effectiveness of CDs. The exploration of CDs' applications in photo-induced treatments further solidified their significance, positioning them as photosensitizers (PS) in photodynamic therapy (PDT) and photothermal agents (PA) in photothermal therapy (PTT). In PDT, CDs triggered the generation of ROS upon light exposure, facilitating cancer cell elimination, while in PTT, they induced localized hyperthermia within cancer cells, enhancing therapeutic outcomes. In vitro and in vivo investigations validated CDs' efficacy in PDT and PTT, affirming their potential for integration into combination therapies. Looking ahead, the future of CDs in anticancer treatment encompasses bioavailability, biocompatibility, synergistic treatments, tumor targeting, artificial intelligence (AI) and robotics integration, personalized medicine, and clinical translation. This transformative odyssey of CDs as future anticancer agents is poised to redefine the paradigm of cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM), Pulau Pinang 11800, Malaysia.
- King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia.
- King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia; Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St., A…
- Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM), Pulau Pinang 11800, Malaysia. Electronic address: srisasidharan@yahoo.com.
Förderung
- Universiti Sains Malaysia
- Deanship of Scientific Research, King Khalid University
- Georgia Research Alliance
Zitieren
APA
Jing, H. H., Shati, A. A., Alfaifi, M. Y., Elbehairi, S. E. I., & Sasidharan, S. (2025). The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2024.01.034
Vancouver
Jing HH, Shati AA, Alfaifi MY, Elbehairi SEI, Sasidharan S. The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond. Journal of Advanced Research. 2025. doi:10.1016/j.jare.2024.01.034
BibTeX
@article{Jing2025,
author = {Jing, Hong Hui and Shati, Ali A and Alfaifi, Mohammad Y and Elbehairi, Serag Eldin I and Sasidharan, Sreenivasan},
title = {The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond},
journal = {Journal of Advanced Research},
year = {2025},
doi = {10.1016/j.jare.2024.01.034}
}
EUVIMED